Literature DB >> 10189066

Diurnal variations of opioid peptides and synenkephalin in vitro release in the amygdala of kindled rats.

M Asai1, M Zubieta, G Matamoros-Trejo, G Linares, P Agustín.   

Abstract

Pentylenetetrazol (PTZ) kindling was induced in male Wistar rats (250-300 g) by daily intraperitoneal injections of 35 mg/kg of the convulsant agent. Immunoreactive (IR)-Met-enkephalin (IR-ME), IR-Leu-enkephalin (IR-LE), IR-heptapeptide (IR-HE), IR-octapeptide (IR-OC) and IR-synenkephalin (IR-Syn) in vitro release was measured from amygdala slices 24 h after the last stimulus, in groups of eight rats, every 4 h beginning at 08:00 h. Opioid peptides in vitro release displayed diurnal variations. IR-ME and IR-Syn showed maximal levels before the onset of darkness (16:00 h). IR-LE and IR-OC release was enhanced 4 h later (20:00 h), no changes were detected for IR-HE. These results show that endogenous opioid system (EOS) release displays diurnal variations. The peak for the analysed peptides was reached before and during the dark phase. It is suggested that EOS release enhancement in PTZ-kindled rats, seems to be due to a compensatory mechanism against the excitation induced by the blockade of the GABAergic transmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189066     DOI: 10.1016/s0143-4179(98)90051-8

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  2 in total

1.  Generation of a novel monoclonal antibody that recognizes the alpha (α)-amidated isoform of a valine residue.

Authors:  Benito Antón Palma; Philippe Leff Gelman; Mayra Medecigo Ríos; Juan Carlos Calva Nieves; Rodolfo Acevedo Ortuño; Maura Epifanía Matus Ortega; Jorge Alberto Hernández Calderón; Ricardo Hernández Miramontes; Anabel Flores Zamora; Alberto Salazar Juárez
Journal:  BMC Neurosci       Date:  2015-10-13       Impact factor: 3.288

2.  An earlier time of scan is associated with greater threat-related amygdala reactivity.

Authors:  David A A Baranger; Seth Margolis; Ahmad R Hariri; Ryan Bogdan
Journal:  Soc Cogn Affect Neurosci       Date:  2017-08-01       Impact factor: 3.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.